SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare is currently trading at Rs. 378.00, up by 18.00 points or 5.00% from its previous closing of Rs. 360.00 on the BSE.

The scrip opened at Rs. 372.00 and has touched a high and low of Rs. 378.00 and Rs. 372.00 respectively. So far 743 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 388.45 on 15-Jan-2020 and a 52 week low of Rs. 139.90 on 02-Aug-2019.

Last one week high and low of the scrip stood at Rs. 388.45 and Rs. 359.95 respectively. The current market cap of the company is Rs. 347.04 crore.

The promoters holding in the company stood at 67.32%, while Institutions and Non-Institutions held 0.01% and 32.67% respectively.

Themis Medicare is presently negotiating with various parties for utilising spare capacity for carrying out contract manufacturing of finished products, and if negotiations are successful, the company will enter into contracts with such parties.

Further, pursuant to notification issued by Ministry of Road Transport and Highways, Government of India, making it mandatory to include Feracrylum 1% Gel 15gms in first aid kit for all types of vehicles coming out from the Auto Manufacturers, the company has started receiving orders for supply of Feracrylum 1% Gel 15gms to be included in first aid kit and is likely to receive similar such orders in future.

Themis Medicare (TML) is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations.

Themis Medicare Share Price

89.50 -0.75 (-0.83%)
20-Apr-2026 11:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.10
Dr. Reddys Lab 1238.10
Cipla 1238.70
Zydus Lifesciences 942.95
Lupin 2327.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×